Maria Inmaculada
Heras Fernando
Asociado Ciencias de la Salud
Hospital Universitario de Valme
Sevilla, EspañaPublications in collaboration with researchers from Hospital Universitario de Valme (1)
2020
-
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 8, pp. 1534-1542